Reuters: Health
ResTORbio Inc said on Friday it had stopped testing its lead drug as a treatment for respiratory illness after it failed to meet the main goal in a late-stage trial, sending the company's shares down nearly 70%.
ResTORbio stops testing lead drug for respiratory illness; shares plummet
ResTORbio stops testing lead drug for respiratory illness; shares plummet
Reuters: Health
ResTORbio Inc said on Friday it had stopped testing its lead drug as a treatment for respiratory illness after it failed to meet the main goal in a late-stage trial, sending the company's shares down nearly 70%.
Reuters: Health
ResTORbio Inc said on Friday it had stopped testing its lead drug as a treatment for respiratory illness after it failed to meet the main goal in a late-stage trial, sending the company's shares down nearly 70%.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment